US FDA Allows More Time to Comment on Proposed Rule for Combo Products

International Medical Device Regulatory Monitor
At the request of stakeholders, the U.S. Food and Drug Administration (FDA) has extended the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.

To View This Article:


Buy This Article Now

Add this article to your cart for $20.00